Description

Benzamide, 4-[5-(3,5-Dichlorophenyl)-4,5-Dihydro-5-(Trifluoromethyl)-3-Isoxazolyl]-2-Methyl- is a high-purity, advanced pharmaceutical intermediate characterized by its complex heterocyclic structure incorporating trifluoromethyl and dichlorophenyl groups. This compound matters for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly those targeting specific biological pathways. It is primarily needed by research institutions and manufacturers in the pharmaceutical, agrochemical, and specialty chemical industries engaged in developing new therapeutic agents and crop protection solutions.

Application

• Pharmaceutical Intermediate: Key precursor in the research and synthesis of new drug candidates, especially for central nervous system (CNS) and anti-inflammatory targets.
• Agrochemical Research: Serves as a core scaffold for developing novel herbicides and fungicides with enhanced activity and selectivity.
• Chemical Synthesis: Used in organic synthesis for constructing complex molecules containing isoxazoline and benzamide motifs.
• Biochemical Research: Employed as a reference standard or ligand in biochemical assays and pharmacological studies.
• Material Science: Potential monomer or additive in the development of advanced polymeric materials with specific functional properties.

Basic Information

Product Name	Benzamide, 4-[5-(3,5-Dichlorophenyl)-4,5-Dihydro-5-(Trifluoromethyl)-3-Isoxazolyl]-2-Methyl-
CAS No.	864730-52-9
Molecular Formula	C18H13Cl2F3N2O2
Molecular Weight	417.21 g/mol
Synonyms	4-[5-(3,5-Dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-2-methylbenzamide; 2-Methyl-4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]benzamide; Benzamide, N-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-2-methyl-; AGN-PC-0E40K7; MLS-0410797; BDBM50389395; ZINC000004098756; AKOS005258209
EINECS	Contact for details

Quality Control

Our Benzamide, 4-[5-(3,5-Dichlorophenyl)-4,5-Dihydro-5-(Trifluoromethyl)-3-Isoxazolyl]-2-Methyl- is produced under strict quality management systems. Every batch undergoes rigorous analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with each shipment, detailing all critical specifications. Our commitment to quality supports compliance with cGMP and ICH guidelines where applicable for pharmaceutical development.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). Keep away from heat, sparks, and open flame. Due to its light-sensitive nature, handling and storage should minimize exposure to direct light.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.